Skip to main content
. 2020 May 15;11:141–162. doi: 10.2147/JBM.S206027

Table 1.

Suggested Hematologic Malignancies Follow-Up After Persistent Complete Remission Achievement

Disease Suggested Follow-Up
Aplastic anemia and
other non-malignant diseases
● annual CBC
Lymphoma and
chronic lymphocytic leukemia
● annual chest X-Ray (if symptoms or previous localization) and abdomen US in indolent lymphomas, up to 5 years after HSCT, then only if clinically indicated
● periodic peripheral lymph nodes palpation for all others223
Acute leukemia, myelodysplastic and myeloproliferative syndromes ● annual CBC
● bone marrow examination with search for minimal residual disease up to 5 year after HSCT (3, 6, 12, 18, 24 months after HSCT, annual after second year post-transplant)
Multiple myeloma ● serum protein electrophoresis, serum free-light chain ratio, urine and serum immunofixation every 6 months
● imaging only if symptoms

Abbreviations: CBC, complete blood count; US, ultrasound; HSCT, hematopoietic stem-cell transplant.